FY2024 Earnings Estimate for TriMas Issued By Zacks Research

TriMas Co. (NASDAQ:TRS) – Research analysts at Zacks Research boosted their FY2024 EPS estimates for shares of TriMas in a research report issued on Monday, January 27th. Zacks Research analyst M. Das now expects that the industrial products company will earn $1.71 per share for the year, up from their previous forecast of $1.70. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q2 2025 earnings at $0.54 EPS, Q4 2025 earnings at $0.48 EPS, FY2025 earnings at $2.04 EPS, Q1 2026 earnings at $0.50 EPS, Q2 2026 earnings at $0.53 EPS and Q3 2026 earnings at $0.56 EPS.

TriMas (NASDAQ:TRS) last announced its quarterly earnings data on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.14). The firm had revenue of $229.36 million during the quarter, compared to analyst estimates of $239.33 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The firm’s revenue for the quarter was down 2.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.57 earnings per share.

Other equities analysts have also issued reports about the stock. BWS Financial restated a “buy” rating and set a $40.00 price target on shares of TriMas in a research report on Thursday, January 23rd. StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th.

TriMas Stock Down 0.1 %

Shares of NASDAQ TRS opened at $24.47 on Thursday. The firm has a market cap of $992.75 million, a price-to-earnings ratio of 38.23 and a beta of 0.67. The company’s 50-day simple moving average is $24.99 and its 200-day simple moving average is $25.44. TriMas has a 52-week low of $22.24 and a 52-week high of $28.51. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60.

Hedge Funds Weigh In On TriMas

Several large investors have recently added to or reduced their stakes in TRS. Intech Investment Management LLC bought a new stake in TriMas during the third quarter valued at $269,000. Paloma Partners Management Co bought a new position in shares of TriMas in the third quarter worth $293,000. XTX Topco Ltd acquired a new stake in TriMas in the third quarter worth about $371,000. Algert Global LLC lifted its stake in shares of TriMas by 4.2% in the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock worth $403,000 after acquiring an additional 639 shares during the period. Finally, Inspire Investing LLC increased its position in shares of TriMas by 17.4% during the 3rd quarter. Inspire Investing LLC now owns 16,155 shares of the industrial products company’s stock valued at $412,000 after purchasing an additional 2,389 shares during the period. 99.42% of the stock is currently owned by hedge funds and other institutional investors.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.